Safety and tolerability of of standard antiviral therapy (peginterferon + ribavirin) in combination with deferasirox in patients with chronic hepatitis C and chronic transfusion-dependent anemias.
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2015
At a glance
- Drugs Deferasirox (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions
- 02 Mar 2015 New trial record